Resonac Holdings (4004.T) — 2022Q4 FY2022 Earnings Call Analysis

Operating Losses Hit JPY 14B While 2025 Margin Targets Remain Anchored

Management withdrew full-year guidance yet kept 2025 targets unwavering despite a JPY 14 billion Q1 loss forecast.

Thesis: Resonac is a leveraged chemical conglomerate masquerading as a semiconductor materials play. The 8-point margin expansion bridge to 2025 is a mathematical fantasy. Internal inventory is ballooning while customers destock. This divergence combined with high debt makes the stock a primary short candidate.

Verdict: SHORT — Conviction: HIGH

Catalyst: Realization of the JPY 14 billion Q1 operating loss and potential debt covenant pressure.

Key Risk: Rapid cyclical recovery in Hard Disk Drive media or faster-than-expected high-multiple asset divestitures.

The Tell: CFO Somemiya admitted his tone was 'considerably different' from CEO Takahashi's. This confirms the internal disconnect between the 'vision' and the 'grim' accounting reality.

Detected Patterns

Friction Level: HIGH_FRICTION — The achievability of the 2025 20% EBITDA margin target. The bull sees a cyclical bottom in hard disk media and a restructuring payoff. The bear sees a debt-laden chemical conglomerate in structural denial with ballooning inventory and no AI leverage.

Report not found

The report data is no longer available. Please return to the archive.

Operating Losses Hit JPY 14B While 2025 Margin Targets Remain Anchored | Silicon Signal